MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
3.470
+0.050 (1.46%)
At close: Mar 11, 2025, 4:00 PM
3.250
-0.220 (-6.34%)
After-hours: Mar 11, 2025, 6:13 PM EST
MaxCyte Employees
MaxCyte had 143 employees as of December 31, 2023. The number of employees increased by 18 or 14.40% compared to the previous year.
Employees
143
Change (1Y)
18
Growth (1Y)
14.40%
Revenue / Employee
$270,119
Profits / Employee
-$287,098
Market Cap
363.03M
Employees Chart
MXCT News
- 11 hours ago - MaxCyte, Inc. (MXCT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 15 hours ago - MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance - GlobeNewsWire
- 4 weeks ago - MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs - GlobeNewsWire
- 4 weeks ago - MaxCyte to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025, and Participate in Upcoming Investor Conference - GlobeNewsWire
- 5 weeks ago - Glancy Prongay & Murray LLP Announces Investigation of MaxCyte, Inc. (MXCT) - Business Wire
- 5 weeks ago - MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments - GlobeNewsWire
- 2 months ago - MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - MaxCyte Announces Retirement of Board Member Art Mandell - GlobeNewsWire